Quality-of-life outcomes in men treated for localized prostate cancer.
about
Waning sexual function--the most important disease-specific distress for patients with prostate cancerThe primary health care physician and the cancer patient: tips and strategies for managing sexual healthEmotional isolation: prevalence and the effect on well-being among 50-80-year-old prostate cancer patientsLack of comprehension of common prostate cancer terms in an underserved population.Psychological adjustment of men with prostate cancer: a review of the literature.How Serious Is Erectile Dysfunction in Men's Lives? Comparative Data From Korean Adults.Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database.Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients.Personal digital assistant data capture: the future of quality of life measurement in prostate cancer treatment.Posterior reconstruction and anterior suspension with single anastomotic suture in robot-assisted laparoscopic radical prostatectomy: a simple method to improve early return of continence.Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer.Pelvic Floor Reconstruction After Radical Prostatectomy: A Systematic Review and Meta-analysis of Different Surgical Techniques.Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patientsTreatment decisions for localized prostate cancer: asking men what's important.The measurement of symptoms, quality of life and sexual function.The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.Brachytherapy versus radical prostatectomy.Prostate cancer screening--is the controversy resolved?Clinical Evidence: Non-metastatic prostate cancer.Sexuality rehabilitation.Effectiveness of preoperative pelvic floor muscle training for urinary incontinence after radical prostatectomy: a meta-analysisUser-centered design of quality of life reports for clinical care of patients with prostate cancer.Sexual rehabilitation after localized prostate cancer: current interventions and future directions.Measuring illness uncertainty in men undergoing active surveillance for prostate cancerProstate cancer and health-related quality of life: a review of the literature.Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters.Carrier testing of children for two X linked diseases in a family based setting: a retrospective long term psychosocial evaluation.Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study.Spiritual well-being and health-related quality of life in colorectal cancer: a multi-site examination of the role of personal meaning.Sexual dysfunction and spousal communication in couples coping with prostate cancer.Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?Efficacy of Duloxetine in the Early Management of Urinary Continence after Radical Prostatectomy.Prostate cancer screening: Attitudes and practices of family physicians in OntarioEvaluation of patient-reported quality-of-life outcomes after renal surgery.Assessing the impact of cancer: development of a new instrument for long-term survivors.Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397).Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.Management of prostate cancer. Part 2: localized and locally advanced disease.Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
P2860
Q24679965-5F948F0C-FEC6-4782-A95B-23A9D46E5081Q26773683-EDFDF17F-154B-467B-B4FC-CB0C61C5DAE9Q28202410-286B7CFF-5CA6-426E-8BAE-D70203D9EABAQ30436410-ABAD04E3-FA4A-4261-BB3B-692AF0984CA9Q30479039-E58FB7F1-64BC-49DB-AF29-BCF269666E15Q30656816-EEF3E090-1797-4907-9B3E-D1035D1A39A3Q33495619-6423489C-35B5-4F4A-A2C3-BC7CAC8F7D81Q33616692-2DF5D156-3EF0-4EBF-9103-99C9DE97E89FQ33698919-F7630EEA-0D0E-4276-9A7F-6148A0C65762Q33722239-674F2DF1-2071-4D10-8FF9-15686B313C91Q33754012-9DB53F0E-08ED-490C-B0E8-B1A4555834DAQ33758761-67559E59-3A0B-4DD6-B4CE-0B09DA3E5BA9Q33773297-31A807B3-2C75-416D-A1B0-E0142FC4FA89Q33843865-478E9FFD-A86A-46BB-AE7A-3E8FDC82E4CBQ33886344-040F246A-A5B9-48AE-90F6-499264E3E6ADQ33958709-F5CDFAE7-8AFD-4ED4-805E-76154E555F6BQ34135234-F66C396C-E8F7-4585-9DEC-B1C567124783Q34181306-ED3B4039-6DF7-4E9B-A4A1-5AF59E07A1AFQ34191176-F3F109AA-76E4-4DA0-99FA-3093644F0EF2Q34344296-955F5EB6-BACC-4B6A-9AB8-5E3EB8A04036Q34454216-DDE05D42-EEEC-4A42-B925-247A41470873Q34541445-CD2EF083-2EFB-43E2-9E85-9A0593454984Q34575573-A8E3E9EF-DB4D-4E11-8BB7-A19D841A9ECAQ34761875-CA9EB6E4-411C-48AF-A248-ACD431981739Q34804009-75450B2B-6664-4C5D-8B75-2E1D7AD598CBQ35547481-6CA47936-0CD2-4353-ABC8-45261302350FQ35571101-7BD2B9FE-D729-4A5F-B898-E37B55DEDCB1Q35680616-B21CE3B5-0D38-44DE-8798-50A1A2DFE2AEQ35760083-9E7A688B-0E51-4506-8A47-C6A044179D75Q35766182-132DA935-3FFB-40A5-A42D-E09FF5A889C6Q35785290-43B36420-03B2-4C85-AF8F-355A4494788BQ35789548-B5861EF4-3ADE-4F77-A4DD-CABE710CF04AQ36007393-914C2DE0-8683-44FC-ADF4-AACBD9FD1050Q36007892-0EECDF38-AE72-43B6-BEC4-778932F59ACAQ36227510-82281A06-8D3E-416B-BE80-EDBA4E4C1A48Q36326326-FDF3B94D-2467-4432-BA42-F5A7C834AADEQ36373823-5F2A9F81-8466-4BED-A04D-E0C8859612A0Q36378954-4C0442E3-CF6E-4C2F-A576-9E5478BA4E4DQ36448693-91E9DAA5-9EC1-4B1E-AF37-150C00FDFB86Q36518253-C6F82646-9E22-42A3-8ADB-9348C91CE7AA
P2860
Quality-of-life outcomes in men treated for localized prostate cancer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Quality-of-life outcomes in men treated for localized prostate cancer.
@en
Quality-of-life outcomes in men treated for localized prostate cancer.
@nl
type
label
Quality-of-life outcomes in men treated for localized prostate cancer.
@en
Quality-of-life outcomes in men treated for localized prostate cancer.
@nl
prefLabel
Quality-of-life outcomes in men treated for localized prostate cancer.
@en
Quality-of-life outcomes in men treated for localized prostate cancer.
@nl
P2093
P1476
Quality-of-life outcomes in men treated for localized prostate cancer.
@en
P2093
M S Litwin
P304
P356
10.1001/JAMA.1995.03520260051032
P407
P577
1995-01-01T00:00:00Z